Drug Shortage Report for RIVA LEUCOVORIN
Report ID | 106795 |
Drug Identification Number | 02493357 |
Brand name | RIVA LEUCOVORIN |
Common or Proper name | Riva Leucovorin |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LEUCOVORIN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 24 |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-02-20 |
Actual start date | 2020-02-20 |
Estimated end date | Unknown |
Actual end date | 2020-09-30 |
Shortage status | Resolved |
Updated date | 2020-12-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-02-20 | English | Compare |
v2 | 2020-02-20 | French | Compare |
v3 | 2020-02-21 | English | Compare |
v4 | 2020-12-04 | English | Compare |
v5 | 2020-12-04 | French | Compare |
Showing 1 to 5 of 5